D. Neau - Concepedia

Author

D. Neau

Inserm

Also Known As

A Mélard, C Duvivier, C Rouzaud, D NEAU, D Neau, D Néau, D. NEAU, D. Neau, DIDIER NEAU, Didier Neau

335

Publications

5.8K

Citations

H-Index

105

Concepts

All Affiliations

Inserm Centre Hospitalier Universitaire de Bordeaux Hôpital Pellegrin Bordeaux Population Health Hôpital Saint-André

About

D. Neau is an author at Inserm specializing in medicine, hiv, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	36	1.4K
2	Public Health	11	11	339
3	Health Sciences	1	1	165
4	Social Sciences	1	1	32
5	Allergy	1	1	83

D. Neau

101

Publications

4.6K

Citations

H-Index

Page 1

	Year	Citations
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial François-Xavier Lescure, Hitoshi Honda, Robert Fowler, The Lancet Respiratory Medicine	2021	246
Lipodystrophy, Metabolic Disorders, and Human Immunodeficiency Virus Infection: Aquitaine Cohort, France, 1999 Rodolphe Thiébaut, V. Daucourt, P. Mercié, Clinical Infectious Diseases	2000	175
Wild-Mushroom Intoxication as a Cause of Rhabdomyolysis R. Bédry, Isabelle Baudrimont, Gérard Deffieux, New England Journal of Medicine Wild-mushroom IntoxicationHealth SciencesMedicineMycotoxin FormationAmanita Phalloides.1	2001	165
Cognitive disorders in HIV-infected patients Fabrice Bonnet, Hélène Amieva, Fabienne Marquant, AIDS	2012	137
Causes of death among HIV‐infected patients in the era of highly active antiretroviral therapy, Bordeaux, France, 1998–1999 Fabrice Bonnet, Philippe Morlat, Geneviève Chêne, HIV Medicine	2002	118
Role of Uncontrolled HIV RNA Level and Immunodeficiency in the Occurrence of Malignancy in HIV‐Infected Patients during the Combination Antiretroviral Therapy Era: Agence Nationale de Recherche sur le Sida (ANRS) CO3 Aquitaine Cohort Mathias Bruyand, Rodolphe Thiébaut, S. Lawson‐Ayayi, Clinical Infectious Diseases	2009	115
Human Immunodeficiency Virus Type 1 Genotypic and Pharmacokinetic Determinants of the Virological Response to Lopinavir-Ritonavir-Containing Therapy in Protease Inhibitor-Experienced Patients Bernard Masquelier, Dominique Breilh, D. Neau, Antimicrobial Agents and Chemotherapy	2002	111
Transmission of HIV-1 minority-resistant variants and response to first-line antiretroviral therapy Olivia Peuchant, Rodolphe Thiébaut, Sophie Capdepont, AIDS	2008	99
Carotid intima–media thickness is slightly increased over time in HIV‐1‐infected patients<sup>*</sup> P. Mercié, Rodolphe Thiébaut, Valérie Aurillac-Lavignolle, HIV Medicine	2005	98
Urolithiasis in HIV-Positive Patients Treated with Atazanavir C. Couzigou, Michel Daudon, J.‐L. Meynard, Clinical Infectious Diseases Protease InhibitorsUrological ResearchUrologyAtazanavir-associated UrolithiasisTreatment And Prevention	2007	97

Page 1